NEW YORK (GenomeWeb) – A new sequencing study of titin, a major gene involved in dilated cardiomyopathy, in more than 5,200 individuals has allowed researchers to distinguish pathogenic variants from benign ones, pointing toward improved diagnostic genetic testing. The results also shed light on the mechanism by which mutations in titin cause DCM, suggesting new treatment avenues.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.